Introduction
Cellular water content, which accounts for -70% of the cellular mass, is the main determinant of cell volume. In animal cells, which are devoid of rigid walls, it is generally accepted that the water content is dictated by the amount of osmotically active cellular particles. Inorganic ions constitute a major fraction of the cellular osmolytes. It is therefore not surprising that changes in the cellular content of these ions underlie the homeostatic processes whereby many cell types regulate their volume. Many cells maintain their size despite changes in the tonicity of the medium. Thus, osmotically shrunken cells reswell towards their original volume by taking up Na+ and CI-, which are rapidly followed by osmotically obliged water. The purpose of this report is to briefly summarize our current knowledge of the mechanisms underlying this regulatory volume increase (RVI) and to discuss some recent findings from our laboratory.
Net volume gain during RVI is associated with an increased content of both Na+ and K + , attributable primarily to enhanced influx rates (see [l-31 for reviews). The stimulated K + influx is virtually eliminated by cardiac glycosides, indicating translocation via the Na+/K+ pump. Importantly, while the glycosides inhibit K + uptake, they do not preclude RVI. Under these conditions, the volume gain persists but is attributable almost entirely to uptake of Na+, accompanying anions and water. These observations suggested that Na+ influx is the primary phenomenon in RVI and that exchange of Na+ for K + , mediated by the pump, is a secondary process.
Na+/H+ exchange in volume regulation
The involvement of Na+/H+ exchange in RVI was initially suggested by the inhibitory effect of amiloride and related compounds. This notion was subsequently supported by three findings. First, in nominally bicarbonate-free solutions, cell shrinking induces a sizeable ( -0.25 pH unit) cytosolic alkalinization; like RVI itself, this alkalinization can be inhibited by amiloride. Second, in lightly buffered Abbreviations used: pHi, cytosolic pH; RVI, regulatory volume increase. *To whom correspondence should be addressed. media, the internal alkalosis is paralleled by an amiloride-sensitive extracellular acidification, indicative of transmembrane flux of acid equivalents. Finally, no significant changes in membrane potential are recorded during RVI, implying that the comparatively large ionic fluxes occur via electroneutral pathways. Together, these findings are consistent with the notion that activation of Na+/H+ exchange is an essential step in RVI.
The presence of extracellular CI-is absolutely required for RVI [l-31. The volume gain is also inhibited, albeit only partially, by the nominal omission of bicarbonate. These observations fit the model initially suggested by Cala [4] , whereby activation of the cation antiport is paralleled by enhanced CVHCO; activity. The model is substantiated by the observation that the C1-influx during RVI is electroneutral, insensitive to changes in membrane potential and strictly dependent on the availability of a transported anion (normally HCO,?) on the trans side of the membrane. Importantly, the flux is inhibited by disulphonic stilbenes, a hallmark of anion exchange.
According to Cala's original model [4] , the primary event during RVI is the activation of Na+/ H+ exchange. The coupling between cation and anion exchange is thought to be a secondary and indirect process, mediated through changes in the intracellular bicarbonate concentration. These changes result from the elevation in cytosolic pH (pH,) that is a consequence of activation of Na+/ H+ exchange. Whereas Cala envisioned the stimulation of anion exchange to be the result of the increased substrate (bicarbonate) concentration only, an additional mechanism was later elucidated by Olsnes and collaborators [ 51. These investigators found that the anion exchangers of at least some mammalian cells are exquisitely sensitive to pH, changes in the physiological range, their activity being greatly stimulated as the cytosol becomes alkaline. Hence, by increasing pH,, activation of the Na+/H+ antiporter would conceivably stimulate anion exchange directly, independently of changes in the concentration of cytosolic bicarbonate.
Under physiological conditions, pH, is the primary determinant of the rate of Na+/H+ exchange. The pronounced sensitivity of the antiport to pHi has been attributed to the existence of an allosteric modifier site that controls the rate of cation countertransport [6] . When protonated, the modifier site activates cation exchange, protecting the cytosol against excessive acidification. As pH, approaches neutrality, deprotonation of the allosteric site curtails the activity of the antiport, preventing alkalinization of the cytosol beyond the physiological set point. Direct measurements of pH, have shown that the activation of Na+/H+ exchange occurring during RVI is not preceded by cytosolic acidification. It must be concluded, therefore, that stimulation of exchange is a consequence of changes in the properties of the antiporter and not of alterations in driving force or in the concentration of allosteric activators. Indeed, when the pH, dependence of transport was explored in detail, a sizeable shift in the alkaline direction was detected [7] . As a result, although the antiport is nearly quiescent at normal pH, in iso-osmolar media, significant transport is observed at a comparable pH, when the cells shrink in hypertonic media. Inasmuch as the modifier site largely defines the pH, dependence of the unstimulated antiport, the alkaline shift induced by osmotic challenge has been attributed to an alteration in the behaviour of this site.
Mitogens, hormones and other chemical stimuli also activate Na+/H+ exchange (see [S] for review). As in the case of RVI, stimulation by chemical agents is associated with cytosolic alkalosis, resulting from an upward displacement in the pH, set point of the modifier site. The similarity of the two effects is further stressed by the observation that they are not additive: maximal osmotic activation entirely precludes subsequent stimulation by growth promoters and other receptor-mediated stimuli. Moreover, both forms of activation appear to depend on the availability of intracellular ATP, as metabolic depletion obliterates hypertonic as well as receptor-induced activation. Such observations prompted the suggestion that phosphorylation plays an important role in the activation of the Na+/H+ antiport. Studies of phosphoprotein content of control and osmotically activated cells revealed the appearance of at least one phosphorylated polypeptide in response to cell shrinking [9] . These studies pre-dated the molecular identification of the antiport, so the identities of the responsive phosphoproteins were not defined.
Because phorbol esters effectively stimulate Na+ /H+ exchange, activation of protein kinase C was postulated to mediate the osmotic activation of the antiport. Yet, information acquired subsequently disproved this notion. First, no decrease in PtdIns(4,5)P2 levels was noted in osmotically shrunken cells. Also, the concentrations of inositol phosphates were not modified under these conditions, suggesting that diacylglycerol was not released by phospholipase C. More definitively, the osmotic activation of Na+ /H+ exchange was found to persist in cells that were depleted of protein kinase C by down-regulation with high doses of phorbol esters (see [ 11 for review). It was therefore concluded that the antiport could be stimulated by at least two convergent pathways, one involving protein kinase C and another initiated by cell shrinking, which is independent of this kinase.
Is the antiporter phosphorylated during volume regulation?
New vistas into the mechanism of osmotic activation were opened by the identification of the molecular species responsible for Na + /H+ exchange. Pouyssegur and collaborators [ 101 identified the entity that mediates cation exchange as an integral membrane glycoprotein of -100 kDa, which they termed M E -1 . Based on hydropathy plots of the deduced primary sequence, NHE-1 was suggested to have two distinct domains: a largely hydrophobic N-terminal region of -500 residues, which was proposed to span the membrane 10-12 times, and a hydrophilic C-terminal domain of > 300 residues, thought to extend into the cytosol. NHE-1 was later found to be only the prototype of a family composed of multiple, related isoforms. So far, four isoforms, designated NHE-1 to -4, have been described in mammalian tissues [ 1 1 -131. NHE-1 appears to be the predominant species in nonepithelial cells and is also present on the basolateral surface of epithelia. This so-called 'housekeeping' isoform of the antiport is thought to be primarily responsible for pH, homeostasis and is also the form of the antiport that is responsive to growth promoters. Accordingly, NHE-1 undergoes phosphorylation upon stimulation of the cells with growth factors, tumour-promoting phorbol esters or phosphatase antagonists [14] [15] [16] .
NHE-1 is seemingly also the isoform that mediates RVI, at least in non-epithelial cells. This is suggested by experiments in which cells deficient in antiport activity were transfected with cDNA encoding NHE-1. Whereas the antiport-deficient cells failed to alkalinize in response to hypertonic stress, the amiloride-sensitive alkalinization was restored in the transfectants [ 171. Moreover, whereas antiport-deficient Chinese hamster ovary cells were found to remain shrunken after osmotic challenge, cells expressing NHE-1 reswelled towards their original volume.
Because the antiport is phosphorylated when activated by growth factors, and considering the kinetic similarities between the receptor-induced and osmotic responses, we hypothesized that stimulation by hypertonic shrinking was similarly mediated by phosphorylation of NHE-1. T o test this possibility, cells were metabolically labelled with ["P]Pi and NHE-1 was immunoprecipitated before and after osmotic challenge. As reported earlier, basal phosphorylation was present in isotonic medium. Under conditions where hypertonic stimulation of Na+ /H+ exchange was readily detectable, however, no additional phosphorylation was measurable. Phosphoamino acid analysis and peptide mapping confirmed that the same residues were phosphorylated in control and stimulated cells and ruled out the possibility of phosphorylation of one site with concomitant dephosphorylation of another. We therefore concluded that osmotic activation of the antiport occurs without phosphorylation of NHE-1 and proposed the existence of dual control of Na+ /H+ exchange by phosphorylationdependent and -independent mechanisms [ 171.
Although NHE-1 itself is seemingly not phosphorylated during osmotic activation, it is quite possible that phosphorylation modulates the antiport through ancillary regulatory proteins, which could themselves be kinase substrates. So far, proteins that specifically associate with the antiport have not been described. Although a few phosphoproteins co-sediment with the antiport during immunoprecipitation, their yields are variable and the specificity of the interaction has not been established. More importantly, the extent of phosphorylation of these co-sedimenting polypeptides does not appear to change when the cells are challenged hypertonically. Therefore, if present, ancillary phosphoproteins are loosely associated with NHE-1 and cannot be detected by conventional immunoprecipitation.
It is also possible that the interaction with a phosphorylated regulator is indirect, involving intervening adaptor proteins. One variant of this hypothesis is that the antiport interacts with and is regulated by macromolecular complexes, such as those forming the cytoskeleton. In this regard, it is noteworthy that not only are other transport proteins known to associate with the cytoskeleton (e.g. [ 18, 19] ), but cytoskeleton-disrupting agents have been reported to impair volume regulation in some systems 120,211. T o date, it is not clear whether the Na+ /H+ antiporter interacts with the cytoskeleton. Yet the following circumstantial evidence suggests that this may indeed be the case. First, a fraction of the platelet NHE-1 can be sedimented at low speed following Triton X-100 extraction of the cells (G. Goss, unpublished results). Cytoskeletal elements are thought to constitute the bulk of the Tritoninsoluble material in platelets. Second, immunolocalization experiments indicate that NHE-1 is not homogeneously dispersed on the surface of fibroblasts or Chinese hamster ovary cells [22] . Regions of focal accumulation were noted along lamellipodia and close to sites of attachment of the cells to the substratum. Importantly, actin and other cytoskeletal components were also concentrated in the regions where NHE-1 accumulated. The functional significance of the focal accumulation of NHE-1 is not clear. imaging analysis of the cytosolic pH of single cells by fluorescence microscopy failed to detect subcellular gradients in either resting cells or in cells recovering from an acute acid load [22] . it is possible that localization of the antiport is required for the reported effects of adherence on Na+/H+ exchange 1231. Alternatively, localized influx of Na+ may play a role in cellular motility, by promoting the swelling and detachment of lamellipodia.
In any event, it seems likely that the local sequestration of antiports reflects an interaction with cytoskeletal elements. This is suggested by two observations. A concomitant reorganization of actin into punctate aggregates was observed in these experiments, suggesting a causal relationship between microfilament shortening and redistribution of NHE-1. Second, the antiport was also delocalized when cells were acutely depleted of ATP by treatment with antimycin-A and deoxyglucose. Over the course of 7 min, the antiport dispersed from lamellipodia and acquired a distribution somewhat reminiscent of that seen after cytochalasin treatment. In parallel, the cytoskeleton reorganized and fragmented, yielding a punctate actin pattern which grossly resembled the one described above for cytochalasin-treated cells. Together, these findings are consistent with the idea that NHE-1 may interact with cytoskeletal elements. If such an interaction were capable of modulating the activity of the antiport, a mechanism for transducing cell-volume changes into varying rates of ion transport can be readily envisaged.
Two other mechanisms, not involving protein phosphorylation, can be postulated to account for the ATP dependence of volume regulation. It has been recently suggested that phospholipid asymmetry, which requires ATP, must be maintained for proper function of the Na+/Ca2+ exchanger [24] . Though structurally unrelated to the Na+ /H+ antiporter, the Na+/Ca2+ exchanger is similarly inhibited when ATP is depleted, even though the nucleotide is not hydrolysed during the transport cycle. Like the Na+/Ca2+ exchanger, the N a + / H + exchanger is reported to be sensitive to the lipid microenvironment [25] [27] . This conclusion was reached based on the effects of exogenous guanine nucleotides and toxins known to ADP-ribosylate the a subunits of several G proteins [27] . Because the levels of GTP can be expected to fall in parallel with ATP levels, deactivation of G proteins could mediate the inhibition of cation exchange.
Conclusion
In summary, substantial progress has been made in our quest to understand the mode of activation of Na+ /H+ exchange during RVI, yet many essential pieces of the puzzle remain unsolved. Although we know that NHE-1 is responsive to volume changes, the susceptibility of the other isoforms to osmotic challenge remains undefined. Preliminary experiments suggest that NHE-3 responds in a manner that is diametrically opposed to that reported for NHE-1 (A. Kapus and J. Orlowski, unpublished results). Moreover, the nucleotide requirement and the role of phosphorylation in RVI must be clarified.
Finally, the nature of the interaction of the antiport with the cytoskeleton deserves attention. The identity of cytoskeletal or other proteins that can interact with the antiporter is the subject of current interest.
It will be of great importance to define whether such putative auxiliary proteins modify the transport activity of the exchanger and, in particular, whether they are capable of conveying to the antiporter information relevant to the volume or shape of the cells.
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